RISEDRONATE SODIUM
| Brand name | ATELVIA |
|---|---|
| Active ingredient | RISEDRONATE SODIUM |
| Strength | 35MG |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | October 2010 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7645460 | January 2028 | product |
| 7645459 | January 2028 | product |
| 8246989 | January 2026 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.